Cost effectiveness of Immunisation -John Jackson, President of Western Pacific Pharmaceutical Forum

Cost effectiveness of Immunisation -John Jackson, President of Western Pacific Pharmaceutical Forum

Asia’s population is ageing. By 2050, 62% of Asia’s population will be made up of older adults – making Asia the oldest region in the world.

The United Nations has proclaimed 2021-2030 to be the Decade of Healthy Ageing, to improve the lives of older people, their families and. An equally important and complementary strategy is that of the World Health Organization’s Immunization Agenda 2030, to ensure that everyone, everywhere, at every age, fully benefits from vaccines to improve health and wellbeing – including older adults.

Despite the benefits of vaccination being widely recognised as one of the most effective and cost-saving public health interventions, life-course immunisation uptake rates remain low across Asia-Pacific.

In response, KPMG, the EU-ASEAN Business Council and Sanofi, with the support of the Western Pacific Pharmaceutical Forum have undertaken insight gathering activities across Southeast Asia on the topic of healthy ageing with the role of life-course immunisation. The findings will be announced and discussed at this virtual panel discussion.

Renowned speakers in public policy and planning as well as from the life sciences industry discuss:
What the findings mean for healthy ageing and its related policies in the region
The barriers to life-course immunisation uptake, especially among older adults
Multi-sectorial interventions to raising the value and importance of life-course immunisation

effectivenessImmunisation-John

Post a Comment

0 Comments